Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: Retrospective study of the Camelford water incident

British Medical Journal

Volumn 319, Issue 7213, 1999, Pages 807-811

  Altmann, Paul ^a   Cunningham, John ^b   Dhanesha, Usha ^c   Ballard, Margaret ^d   Thompson, James ^e   Marsh, Frank ^b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c Hospital of Coventry and Warwickshire   (United Kingdom)

^d Southgate   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM SULFATE; DRINKING WATER;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENTAL DISEASE; ORGANIC BRAIN SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC TEST; PSYCHOMOTOR PERFORMANCE; READING; RETROSPECTIVE STUDY; SIBLING; UNITED KINGDOM; WATER CONTAMINATION;

EID: 0033604126     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7213.807     Document Type: Article

References (36)

1. Clavton B, on behalf of Lowermoor Incident Health Advisory Group. Water pollution at Lowermoor. North Cornwall. Truro: Cornwall and Isles of Scilly District Health Authority, 1989.
2. Owen PJ, Miles DP. A review of hospital discharge rates in a population around Camelford in North Cornwall up to the fifth anniversary of an episode of aluminium sulphate absorption. J Public Health Med 1995;17:200-4.
3. Clayton B, on hehalf of Lowermoor Incident Health Advisory Group, Department of Health. Water pollution at Lawermoor, North Cornwall (second report). London: HMSO. 1991.
4. McMillan TM, Freemont AJ, Herxheimer A, Denton J, Taylor AP, Pazianas M, et al. Camelford water poisoning accident: serial neuropsychological assessments and further observations on bone aluminium. Hum Exp Toxicol 1993; 12:37-42.
5. Coggon D, Camelford revisited. BMJ 1991;303:1280-1.
6. Mayon-White RT. How should another Camelford be managed: BMJ 1993;307:398-9.
7. Platts MM, Anastassiades E. Dialysis encephalopathy: precipitating factors and improvement in prognosis. Clin Nephrol 1981;15:223-8.
8. Kachnv WD. Hegg AP. Alfrey AC. Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med 1977;296:1389-90.
9. Altmann P. Butter KC. Plowman D. Chaput de Saintonge DM, Cunningham J. Marsh FP. Residual renal function in hemodialysis patients may protect against hyperaluminemia. Kidney Int 1987;32:710-3.
10. Priest ND, Talbot RJ, Austin JG, Day JP, King SJ, Fifield K, et al. The hioavailability of 26Al-labelled aluminium citrale and aluminium hydroxide in volunteers. Biometals 1996;9:221-8.
11. Altmann P, Al-Salihi F, Butter K, Cutler B, Blair J. Leeming R, et al. Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis, N Engl J Med 1987;317:80-1.
12. Altmann P. Dhanesha U. Hamon C. Cunningham J. Blair J. Marsh F. Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity. Lancet 1989;ii:7-12.
13. Altmann P. The toxie effects of aluminium in haemodialysis patients. London: University of London, 1991 (MD thesis).
14. Nelson HE. The national adult reading text. Windsor: NFER-Nelson, 1982.
15. Lezak MD. Neuropsychological assessment. London: Oxford University Press, 1976.
16. Acker W. Acker C. Bexlry Maudsley automated ppsychological screening and Bexley Maudsley categary sorting test. Windsor: NFER-Nelson, 1982.
17. Curling HMD, Murray RM. Investigations into the genetics of alcohol dependence and into the its effects on brain function. Third International Conference on Twin Studies. Jerusalem 1980.
18. Derogatis L.R. Symptom checklist-90-R: administraction, scaring and procedure manual. Baltimore: Clinical Psychometrics Research, 1977.
19. David AS. Wessely SC. The legend of Camelford: medical consequences of a water pollution accident. J Psychosom Res 1995;39:1-9.
20. Haycock KA Roth J, Gagnon J, Finzer WF, Soper C. Stat View, Berkeley; CA: Abacus Concepts, 1992.
21. McMillan TM, Dunn G, Colwill SJ. Psychological testing on schoolchildren before and after pollution of drinking water in North Cornwall. J child psychot Psychiatry 1993;34:1449-59.
22. Terry RD. Pena C. Experimental production of neurofibrillary degeneration. 2. Electron microscopy phosphatase histochemistry and electron probe analysis. Neuropathol Exp Neurol 1965;23:200-10.
23. Crapper DR, Krishnan SS, Dalton AJ. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 1973; 180:511-3.
24. Perl DP, Brody AR. Alzheimer's disease: x ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 1980;208:297-99.
25. Kellett JM, Taylor A, Oram J. Aluminosilicates and Alzheimer's disease. Lancet 1986;i:682.
26. Barlow PJ. Francois PF., Goldberg I, Richardson I, Izmeth NG, Kumpeson K, et al. Trace metal abnormalities in long-stay hyperactive mentally handicapped children and agitated senile dements. J Roy Soc Med 1986;79:581-3.
27. Mjoberg B, Hellquist F., Mallmin H, Lindh U. Aluminum, Alzheimer's disease and bone fragility Acta Orthop Scand 1997;68:511-4.
28. Birchall JD, Chappell JS. Aluminium, chemical physiology, and Alzheimer's disease. Lancet 1988;ii:1008-10.
29. Doll R. Review: Alzheimer's disease and environmental aluminum. Age Ageing 1993;22:138-53.
30. Flaten TP, Alfrey AC, Birchall JD. Savory J, Yokel RA. Status and future concerns of clinical and environmental aluminum toxicology. J Toxicol Environ Health 1996;48:527-41.
31. Delabar J-M, Goldgaber D, Lamour Y, Nicloe A, Huret JL, de Grouchy J. et al. Beta-amyloid gene duplication in Alzheimer's disease and karyotypically normal Down's syndrome. Science 1987;235:1390-2.
32. Mayeux R, Schupf N. Apolipoprotein E and Alzheimer's disease; the implications of progress in molecular medicine. Am J Public Health 1995;85:1280-4.
33. Cacabelos R, Diagnosis of Alzheimer's disease: defining genetic profiles (genotype vs phenotype). Acta Neurol Scand Suppl 1996;165:72-84.
34. Farrar G, Altmann P, Welch S, Wychrij O, Ghose B, Lejeune J. et al. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain. Lancet 1990;335:747-50.
35. Taylor GA, Ferrier IN, McLoughlin IJ, Fairburn AF, McKeith IG, Lett D, et al. Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate. Age Ageing 1992;21:81-90.
36. Moore PB, Edwardson JA, Ferrier IN, Taylor GA, Lett D, Tyrer SP, et al. Gastrointestinal absorption of aluminium is increased in Down's syndrome, Biol Psychiatry 1997;41:188-92.